A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights

Cellular Signalling

Volumn 28, Issue 6, 2016, Pages 631-642

  Parravicini, Chiara ^a   Daniele, Simona ^a,b   Palazzolo, Luca ^a   Trincavelli, Maria Letizia ^b   Martini, Claudia ^b   Zaratin, Paola ^c   Primi, Roberto ^a   Coppolino, Giusy ^a   Gianazza, Elisabetta ^a   Abbracchio, Maria P ^a   Eberini, Ivano ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Fondazione Italiana Sclerosi Multipla   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemokine receptors; Class A GPCRs; Demyelinating diseases; GPR17; Neuroinflammation; SDF 1

Indexed keywords

CANGRELOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; G PROTEIN COUPLED RECEPTOR; GPR17 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; ADENOSINE PHOSPHATE; CXCL12 PROTEIN, HUMAN; GPR17 PROTEIN, HUMAN; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPLEX FORMATION; COMPUTER MODEL; CONTROLLED STUDY; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; OLIGODENDROCYTE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STRUCTURE ANALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CHEMISTRY; METABOLISM; MOLECULAR DOCKING; SPRAGUE DAWLEY RAT;

ADENOSINE MONOPHOSPHATE; ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL12; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84961180696     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.03.001     Document Type: Article

References (66)

1. Shirozu M., Nakano T., Inazawa J., Tashiro K., Tada H., Shinohara T., Honjo T. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995, 28:495-500.
2. Lataillade J.J., Clay D., Bourin P., Herodin F., Dupuy C., Jasmin C., Le Bousse-Kerdiles M.C. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 2002, 99:1117-1129.
3. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
4. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9448-9453.
5. Lewellis S.W., Knaut H. Attractive guidance: how the chemokine SDF1/CXCL12 guides different cells to different locations. Semin. Cell Dev. Biol. 2012, 23:333-340.
6. Ma Q., Jones D., Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999, 10:463-471.
7. Li M., Hale J.S., Rich J.N., Ransohoff R.M., Lathia J.D. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 2012, 35:619-628.
8. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-833.
9. Graham G.J., Locati M., Mantovani A., Rot A., Thelen M. The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 2012, 145:30-38.
10. Williams J.L., Holman D.W., Klein R.S. Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front. Cell. Neurosci. 2014, 8.
11. Naumann U., Cameroni E., Pruenster M., Mahabaleshwar H., Raz E., Zerwes H.G., Rot A., Thelen M. CXCR7 functions as a scavenger for CXCL12 and CXCL11. Plos One 2010, 5.
12. Patel J.R., McCandless E.E., Dorsey D., Klein R.S. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11062-11067.
13. Odemis V., Boosmann K., Heinen A., Kury P., Engele J. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J. Cell Sci. 2010, 123:1081-1088.
14. Pawig L., Klasen C., Weber C., Bernhagen J., Noels H. Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives. Front. Immunol. 2015, 6.
15. Williams J.L., Patel J.R., Daniels B.P., Klein R.S. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system. J. Exp. Med. 2014, 211:791-799.
16. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 2005, 48:16-42.
17. Li M., Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 2008, 84:116-131.
18. Mithal D.S., Banisadr G., Miller R.J. CXCL12 signaling in the development of the nervous system. J. NeuroImmune Pharmacol. 2012, 7:820-834.
19. Bakondi E., Catalgol B., Bak I., Jung T., Bozaykut P., Bayramicli M., Ozer N.K., Grune T. Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity. Free Radic. Biol. Med. 2011, 50:86-92.
20. Carbajal K.S., Miranda J.L., Tsukamoto M.R., Lane T.E. CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 2011, 59:1813-1821.
21. Li Y., Tang G., Liu Y., He X., Huang J., Lin X., Zhang Z., Yang G.-Y., Wang Y. CXCL12 gene therapy ameliorates ischemia-induced white matter injury in mouse brain. Stem Cells Transl. Med. 2015, 4.
22. Thelen M., Thelen S. CXCR7, CXCR4 and CXCL12: an eccentric trio?. J. Neuroimmunol. 2008, 198:9-13.
23. Lecca D., Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem. Pharmacol. 2008, 75:1869-1881.
24. Fumagalli M., Daniele S., Lecca D., Lee P.R., Parravicini C., Fields R.D., Rosa P., Antonucci F., Verderio C., Trincavelli M.L., Bramanti P., Martini C., Abbracchio M.P. Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J. Biol. Chem. 2011, 286:10593-10604.
25. Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D., Ferrario S., Parravicini C., Capra V., Gelosa P., Guerrini U., Belcredito S., Cimino M., Sironi L., Tremoli E., Rovati G.E., Martini C., Abbracchio M.P. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 2006, 25:4615-4627.
26. Benned-Jensen T., Rosenkilde M.M. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Br. J. Pharmacol. 2010, 159:1092-1105.
27. Buccioni M., Marucci G., Dal Ben D., Giacobbe D., Lambertucci C., Soverchia L., Thomas A., Volpini R., Cristalli G. Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17. Purinergic Signal 2011, 7:463-468.
28. Maekawa A., Balestrieri B., Austen K.F., Kanaoka Y. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11685-11690.
29. Qi A.D., Harden T.K., Nicholas R.A. Is GPR17 a P2Y/leukotriene receptor? Examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17. J. Pharmacol. Exp. Ther. 2013, 347:38-46.
30. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisakk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
31. Moll N.M., Cossoy M.B., Fisher E., Staugaitis S.M., Tucky B.H., Rietsch A.M., Chang A., Fox R.J., Trapp B.D., Ransohoff R.M. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch. Neurol. 2009, 66:44-53.
32. Franciotta D., Zardini E., Ravaglia S., Piccolo G., Andreoni L., Bergamaschi R., Romani A., Tavazzi E., Naldi P., Ceroni M., Marchioni E. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J. Neurol. Sci. 2006, 247:202-207.
33. Fumagalli M., Bonfanti E., Daniele S., Zappelli E., Lecca D., Martini C., Trincavelli M.L., Abbracchio M.P. The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization. Glia 2015, 63.
34. Fumagalli M., Lecca D., Abbracchio M.P. CNS remyelination as a novel reparative approach to neurodegenerative diseases: the roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology 2015.
35. Raccosta L., Fontana R., Maggioni D., Lanterna C., Villablanca E.J., Paniccia A., Musumeci A., Chiricozzi E., Trincavelli M.L., Daniele S., Martini C., Gustafsson J.A., Doglioni C., Feo S.G., Leiva A., Ciampa M.G., Mauri L., Sensi C., Prinetti A., Eberini I., Mora J.R., Bordignon C., Steffensen K.R., Sonnino S., Sozzani S., Traversari C., Russo V. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J. Exp. Med. 2013, 210:1711-1728.
36. Sensi C., Daniele S., Parravicini C., Zappelli E., Russo V., Trincavelli M.L., Martini C., Abbracchio M.P., Eberini I. Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation. Cell. Signal. 2014.
37. Fredriksson R., Lagerstrom M.C., Lundin L.G., Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003, 63:1256-1272.
38. Raport C.J., Schweickart V.L., Chantry D., Eddy R.L., Shows T.B., Godiska R., Gray P.W. New members of the chemokine receptor gene family. J. Leukoc. Biol. 1996, 59:18-23.
39. Tamamis P., Floudas C.A. Elucidating a key component of cancer metastasis: CXCL12 (SDF-1alpha) binding to CXCR4. J. Chem. Inf. Model. 2014, 54:1174-1188.
40. Eberini I., Daniele S., Parravicini C., Sensi C., Trincavelli M.L., Martini C., Abbracchio M.P. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. J. Comput. Aided Mol. Des. 2011, 25:743-752.
41. Parravicini C., Ranghino G., Abbracchio M.P., Fantucci P. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. BMC Bioinf. 2008, 9:263.
42. Im W., Feig M., Brooks C.L. An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins. Biophys. J. 2003, 85:2900-2918.
43. MacKerell A.D., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S., Gao J., Guo H., Ha S., Joseph-McCarthy D., Kuchnir L., Kuczera K., Lau F.T.K., Mattos C., Michnick S., Ngo T., Nguyen D.T., Prodhom B., Reiher W.E., Roux B., Schlenkrich M., Smith J.C., Stote R., Straub J., Watanabe M., Wiorkiewicz-Kuczera J., Yin D., Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 1998, 102:3586-3616.
44. Fanelli F., Felline A. Dimerization and ligand binding affect the structure network of A2A adenosine receptor. Biochim. Biophys. Acta Biomembr. 2011, 1808:1256-1266.
45. Lomize M.A., Pogozheva I.D., Joo H., Mosberg H.I., Lomize A.L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 2012, 40:D370-D376.
46. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., DiNola A., Haak J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81:3684-3690.
47. Van der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J.C. GROMACS: fast, flexible, and free. J. Comput. Chem. 2005, 26:1701-1718.
48. Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996, 14:33-38. 27-38.
49. Shadnia H., Wright J.S., Anderson J.M. Interaction force diagrams: new insight into ligand-receptor binding. J. Comput. Aided Mol. Des. 2009, 23:185-194.
50. Daniele S., Trincavelli M.L., Gabelloni P., Lecca D., Rosa P., Abbracchio M.P., Martini C. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. J. Pharmacol. Exp. Ther. 2011, 338:559-567.
51. Calleri E., Ceruti S., Cristalli G., Martini C., Temporini C., Parravicini C., Volpini R., Daniele S., Caccialanza G., Lecca D., Lambertucci C., Trincavelli M.L., Marucci G., Wainer I.W., Ranghino G., Fantucci P., Abbracchio M.P., Massolini G. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. J. Med. Chem. 2010, 53:3489-3501.
52. Parravicini C., Abbracchio M.P., Fantucci P., Ranghino G. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach. BMC Struct. Biol. 2010, 10:8.
53. Zhang K., Zhang J., Gao Z.G., Zhang D., Zhu L., Han G.W., Moss S.M., Paoletta S., Kiselev E., Lu W., Fenalti G., Zhang W., Muller C.E., Yang H., Jiang H., Cherezov V., Katritch V., Jacobson K.A., Stevens R.C., Wu B., Zhao Q. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 2014, 509:115-118.
54. de Graaf C., Foata N., Engkvist O., Rognan D. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening. Proteins-Struct. Funct. Bioinf. 2008, 71:599-620.
55. Peeters M.C., van Westen G.J.P., Li Q., Ijzerman A.P. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends Pharmacol. Sci. 2011, 32:35-42.
56. Zhao Q., Wu B.L. Ice breaking in GPCR structural biology. Acta Pharmacol. Sin. 2012, 33:324-334.
57. Veldkamp C.T., Seibert C., Peterson F.C., De la Cruz N.B., Haugner J.C., Basnet H., Sakmar T.P., Volkman B.F. Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12. Sci. Signal. 2008, 1.
58. Huang X.Q., Shen J.H., Cui M., Shen L.L., Luo X.M., Ling K., Pei G., Jiang H.L., Chen K.X. Molecular dynamics simulations on SDF-1 alpha: binding with CXCR4 receptor. Biophys. J. 2003, 84:171-184.
59. Xu L., Li Y.Y., Sun H.Y., Li D., Hou T.J. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches. Mol. BioSyst. 2013, 9:2107-2117.
60. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.L., Baggiolini M., Sykes B.D., Clark-Lewis I. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997, 16:6996-7007.
61. Rajagopalan L., Rajarathnam K. Structural basis of chemokine receptor function - a model for binding affinity and ligand selectivity. Biosci. Rep. 2006, 26:325-339.
62. Wolf S., Grunewald S. Sequence, structure and ligand binding evolution of rhodopsin-like G protein-coupled receptors: a crystal structure-based phylogenetic analysis. PLoS One 2015, 10.
63. Daniele S., Trincavelli M.L., Fumagalli M., Zappelli E., Lecca D., Bonfanti E., Campiglia P., Abbracchio M.P., Martini C. Does GRK-beta arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?. Cell. Signal. 2014, 26:1310-1325.
64. Maysami S., Nguyen D., Zobel F., Pitz C., Heine S., Hopfner M., Stangel M. Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12. Neuroreport 2006, 17:1187-1190.
65. Kothur K., Wienholt L., Brilot F., Dale R.C. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review. Cytokine 2015.
66. Pashenkov M., Soderstrom M., Link H. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J. Neuroimmunol. 2003, 135:154-160.